Cargando…
Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine
BACKGROUND: Subarachnoid hemorrhage (SAH) is a devastating disease that affects over 30,000 Americans per year. Previous animal studies have explored the therapeutic effects of deferoxamine (DFX) via its iron-chelating properties after SAH, but none have assessed the necessity of microglial/macropha...
Autores principales: | LeBlanc, Robert H., Chen, Ruiya, Selim, Magdy H., Hanafy, Khalid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020472/ https://www.ncbi.nlm.nih.gov/pubmed/27618864 http://dx.doi.org/10.1186/s12974-016-0709-1 |
Ejemplares similares
-
Neuroprotection after Hemorrhagic Stroke Depends on Cerebral Heme Oxygenase-1
por: Kaiser, Sandra, et al.
Publicado: (2019) -
Curcumin and Heme Oxygenase: Neuroprotection and Beyond
por: Mhillaj, Emanuela, et al.
Publicado: (2019) -
Subarachnoid Hemorrhage Increases Level of Heme Oxygenase-1 and Biliverdin Reductase in the Choroid Plexus
por: Solár, Peter, et al.
Publicado: (2020) -
Neuroprotective effect of heme oxygenase-2 knockout in the blood injection model of intracerebral hemorrhage
por: Chen-Roetling, Jing, et al.
Publicado: (2014) -
Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage
por: Li, Yanjiang, et al.
Publicado: (2017)